Loading
Ardent Health, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by LUMSDAINE ALFRED, was filed 08 Jun 2026.
Ardent Health, Inc.: what insiders have been doing
This page follows insider dealings at Ardent Health, Inc. as filed with SEC (Form 4), a company from the Health Care sector. The last twelve months, up to 21 October 2026, brought 39 filings signed by 17 insiders.
Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases totalling €160k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The buyers include 1 finance chief and 1 senior executive. One trade stands out by size: a purchase of €85k from DeMichiei Robert, disclosed on 8 June 2026, or 0.0072% of market capitalisation.
Compared with its exchange (5,454 companies, median 22 filings), a count of 39 filings is above the norm. Over the whole record (from 2024), the tally stands at 3 purchases and no sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 6.32 bn USD and net income at 135.8 m USD.
Within a 30-day window, 2 purchases overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The latest purchase dates back some time: it was published 135 days ago, on 8 June 2026. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade.
For comparison within the same sector, see the insider buying recorded at Xenon Pharmaceuticals Inc. and Vivos Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
83
Thresholds
n/a
Buy Volume
€322,322
3 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleAlfred Lumsdaine1 buy
Robert DeMichiei1 buy
Webb Robert Thomas1 buy
Since the insiders bought
- +28.3%Entry US$9.41 · Close 20 Oct 2026 US$12.07
- +28.3%Entry US$9.41 · Close 20 Oct 2026 US$12.07
- -49.4%Entry US$17.81 · Close at T+365 US$9.01
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Ardent Health, Inc. Buy (bullish), based on 12 analysts. Average price target: US$12.67.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 7,519 of 26,281 companies
62.3
score / 100
Value79
Quality46
FCF yld15%
Earn yld7.9%
EV/EBITDA8.1x
ROE10.0%
Gross mgn41%
Net mgn2.1%
Debt/EBITDA4.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$12.12
Analyst consensus
12 analystsBuy
US$10.50Target US$12.67(+5%)US$14.00
Income statement
RevenueUS$6.3B
Gross profitUS$2.6B41% margin
EBITDAUS$497.3M8% margin
Net incomeUS$135.8M1.2% margin
Valuation
PER (trailing)22.4x
PER (forward)9.7x
P/Book1.3x
Beta0.72
Balance sheet & cash
Market capUS$1.7B
Total debtUS$2.3B
Free Cash FlowUS$258.6M
Debt / Equity130%
Profitability & ownership
ROE10.0%
ROA3.1%
% insiders23.8%
% institutions76.8%
Last declaration on 29 September 2026
Declarations83 total
524 shares@ US$10.540.0004% mcap20.4% of flowCommon StockSEC:0001628280-26-063790:0
788 shares@ US$10.540.0006% mcap18.1% of flowCommon StockSEC:0001628280-26-063791:0
3,389 shares@ US$10.540.0024% mcap15.9% of flowCommon StockSEC:0001628280-26-063792:0
35,930 shares@ US$11.0780.026% mcap22.9% of flowCommonSEC144:0001959173-26-006503
35,930 shares@ US$11.17050.026% mcap23.1% of flowCommonSEC144:0001959173-26-006448
35,930 shares@ US$10.50280.024% mcap21.7% of flowCommonSEC144:0001959173-26-006282
35,930 shares@ US$10.95130.026% mcap22.8% of flowCommonSEC144:0001959173-26-006173
103,653 sharesCommon StockSEC:0001628280-26-046788:0
10,000 shares@ US$8.810.0064% mcap45.8% of flowCommon StockSEC:0001628280-26-041444:0
Canonical exit: 3 Sept 2026 (T+90)
11,260 shares@ US$8.730.0072% mcap100.0% of flowCommon StockSEC:0001628280-26-041445:0
Canonical exit: 3 Sept 2026 (T+90)
134,615 shares0Common StockSEC:0001628280-26-023203:2
11,538 shares0Common StockSEC:0001628280-26-023206:2
35,673 shares0Common StockSEC:0001628280-26-023213:1
14,231 shares0Common StockSEC:0001628280-26-023263:0
14,231 shares0Common StockSEC:0001628280-26-023264:0
14,231 shares0Common StockSEC:0001628280-26-023268:0
14,231 shares0Common StockSEC:0001628280-26-023276:0
4,381 shares@ US$8.6719.8% of flowCommon StockSEC:0001628280-26-023205:1
819 shares@ US$8.5632.1% of flowCommon StockSEC:0001628280-26-023206:0
1,808 shares@ US$8.6741.0% of flowCommon StockSEC:0001628280-26-023208:1
2,684 shares@ US$8.67100.0% of flowCommon StockSEC:0001628280-26-023213:0
53,846 shares0Common StockSEC:0001628280-26-023205:2
14,231 shares0Common StockSEC:0001628280-26-023262:0
14,231 shares0Common StockSEC:0001628280-26-023266:0
25 of 83 declarations
About Ardent Health, Inc.
Ardent Health, Inc. is a healthcare company based in the United States, specializing in the management of hospitals and health services. It primarily operates on the XNAS stock market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
